Latest Automation News

QuickFee Limited reports a record A$7.2 million quarterly revenue, driven by strong US and Australian growth, alongside positive underlying profitability and a major refinancing.

MLG Oz Limited has landed a significant 30-month crushing and screening contract with New Murchison Gold, boosting its foothold in Western Australia's gold mining sector.

IODM Limited has secured a new revenue share agreement with TransferMate, broadening its IODM Connect platform's footprint across the Americas' higher education sector.

Praemium Limited reports a 2.2% increase in funds under administration for Q4 FY25, driven by strong gains in Spectrum and SMA platforms, alongside operational upgrades including AI-driven initiatives. However, OneVue platform experiences a significant decline.

Genetic Signatures reported steady quarterly sales of $4.4 million, reflecting seasonal demand in Australia, while restructuring its US operations to accelerate growth. A new US contract and strategic partnerships signal potential for future expansion.

Genetic Signatures has formed a strategic partnership with Tecan and Repado to develop a fully automated, scalable infectious disease testing platform integrating advanced automation, compliant software, and proprietary assays.

Audinate Group has completed its $28 million acquisition of Iris Studio, a US-based leader in AI-powered, cloud-based camera control technology, marking a significant expansion into video production solutions.

Norwood Systems delivered its strongest quarter yet with record cash inflows, significant debt reduction, and expanding global partnerships, setting a robust foundation for FY2026.

Barton Gold Holdings has revealed a preliminary A$26 million refurbishment plan for its Central Gawler Mill, aiming to restart production by the end of 2026 with significant cost and operational advantages.

PIES Holding Co and Activeport Group have launched a strategic joint venture to integrate AI-driven low-code/no-code tools with advanced network orchestration software, aiming to transform telecommunications and data centre operations globally.

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.

Clever Culture Systems has sold its APAS Independence instrument to Novo Nordisk for a comprehensive evaluation across the pharmaceutical giant’s manufacturing network, marking a key step in its global sales strategy.